Cicatricial Alopecia: What's New in Etiology?

    November 2015 in “ European Journal of Inflammation
    Beata Bergler-Czop, Hubert Arasiewicz, Ligia Brzezińska-Wcisło
    Image of study
    TLDR Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.
    The 2015 document discussed cicatricial alopecia, a rare, irreversible hair loss condition caused by the destruction of hair follicles and their replacement with fibrocartilage. The study, which involved 90 skin samples, suggested that damage to epithelial hair follicle stem cells (eHFSCs) and an abnormal immune response were key factors in the disease's development. It also highlighted the role of the peroxisome proliferator-activated receptor (PPAR)-y, a gene regulator, in the pathogenesis of cicatricial alopecia. The study found that over 53% of patients with cicatricial alopecia experienced a decrease in sebaceous glands, compared to less than 5% of patients with non-cicatricial alopecia. The research suggested that lipid metabolism disorders in cicatricial alopecia precede inflammation and are caused by an error in the PPAR-y signaling in the hair follicle and sebaceous glands' stem cells. Environmental and genetic factors were also considered triggers for cicatricial alopecia. However, the exact trigger for the destruction of eHFSCs and the onset of cicatricial alopecia remained unknown at the time of the document's publication.
    Discuss this study in the Community →

    Research cited in this study

    24 / 24 results

    Related Community Posts Join

    6 / 25 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      by nkrata in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  120 upvotes 5 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

      community scarring alopecia awareness in this community

      in Chat  33 upvotes 3 years ago
      Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

      community Exploring Bryan Johnson's Hair Routine In Detail

      in Research/Science  63 upvotes 2 years ago
      Bryan Johnson uses a custom hair loss treatment that includes topical finasteride, minoxidil, azelaic acid, diclofenac, tea tree oil, rosemary oil, ginkgo biloba, biotin, and melatonin, which have shown varying degrees of effectiveness with minimal side effects. He also undergoes PRP and laser therapy, and has tried dutasteride mesotherapy.

    Similar Research

    5 / 1000+ results